RxSight Inc.

NASDAQ: RXST · Real-Time Price · USD
8.41
0.19 (2.31%)
At close: Aug 15, 2025, 3:59 PM
8.47
0.71%
After-hours: Aug 15, 2025, 07:51 PM EDT

RxSight Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
139.93M 89.08M 49.01M 22.59M
Cost of Revenue
40.98M 35.31M 27.68M 18.08M
Gross Profit
98.94M 53.77M 21.33M 4.52M
Operating Income
-36.86M -50.09M -63.32M -52.79M
Interest Income
9.47M 6.57M 1.52M 54K
Pretax Income
-27.41M -48.59M -66.75M -48.68M
Net Income
-27.45M -48.61M -66.76M -48.69M
Selling & General & Admin
101.43M 74.8M 58.66M 32.8M
Research & Development
34.37M 29.05M 25.98M 24.5M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
135.8M 103.85M 84.65M 57.3M
Interest Expense
21K 3.31M 4.95M 3.68M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
176.78M 139.16M 112.32M 75.38M
Income Tax Expense
50K 20K 9K 8K
Shares Outstanding (Basic)
38.87M 34.46M 27.66M 27.37M
Shares Outstanding (Diluted)
38.87M 34.46M 27.66M 27.37M
EPS (Basic)
-0.71 -1.41 -2.41 -1.78
EPS (Diluted)
-0.71 -1.41 -2.41 -1.78
EBITDA
-23.76M -41.04M -57.78M -41.01M
EBIT
-27.38M -45.28M -61.8M -45M
Depreciation & Amortization
3.62M 4.24M 4.02M 3.99M